STTK — Shattuck Labs, Inc.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1680367 ·
Last close
$6.11
Market Cap
$468.52M
52W High
$8.33
52W Low
$3.81
ADV30
520,971
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -15,545,000 | -14,767,000 | 102,121,000 | 90,419,000 | 6,286,000 |
| Dec 2025 | 0 | — | -13,371,000 | -12,593,000 | 91,026,000 | 54,192,000 | 8,636,000 |
| Sep 2025 | 1,000,000 | — | -10,716,000 | -10,056,000 | 100,333,000 | 42,548,000 | 7,093,000 |
| Jun 2025 | 0 | — | -13,032,000 | -12,458,000 | 64,371,000 | 50,467,000 | 7,352,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-39,882,000
Investing CF
$-7,887,000
Financing CF
$44,574,000
CapEx
$-42,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-0.77
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-430,529,000
Inventory
—
Receivables
—
ST Investments
$23,873,000
EBIT TTM
$-51,508,000
Pretax Income TTM
$-48,809,000
Interest Exp TTM
—
Analysts
6
Yahoo Snapshot (yfinance, live)
Total Revenue
$1,000,000
EBITDA
$-48,940,000
Free Cash Flow
$-22,423,376
Enterprise Value
$380,987,968
Total Cash
$90,419,000
Total Debt
$2,889,000
Shares Out
76,680,517
Trailing EPS
$-0.56
Book Value
$1.30
ROE
-61.0%
ROA
-36.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 1,000,000 | -51,508,000 | -48,809,000 | 91,026,000 | 8,636,000 | — | -39,882,000 |
| Dec 2024 | 5,721,000 | -80,567,000 | -75,410,000 | 91,049,000 | 11,423,000 | — | -60,515,000 |
| Dec 2023 | 1,657,000 | -91,957,000 | -87,298,000 | 159,564,000 | 14,859,000 | — | -81,228,000 |
| Dec 2022 | 652,000 | -103,329,000 | -101,945,000 | 205,324,000 | 29,167,000 | — | -94,498,000 |
TTM Snapshot
Revenues TTM
$5,795,000
NetIncome TTM
$-86,261,000
OpCashFlow TTM
$0
Assets (Latest)
$91,049,000
Forward EPS
$-0.51
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | $471.07M | $9.13 | — |
| CATX | Perspective Therapeutics, Inc. | $474.43M | $4.16 | — |
| KMDA | KAMADA LTD | $458.60M | $7.95 | — |
| CYDY | CytoDyn Inc. | $457.62M | $0.34 | — |
| OVID | Ovid Therapeutics Inc. | $457.27M | $2.45 | — |
News headlines (Yahoo Finance, 1h cache)
We're Not Very Worried About Shattuck Labs' (NASDAQ:STTK) Cash Burn Rate
2026-05-11 11:33 · Yahoo
Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights
2026-05-07 10:15 · Yahoo
Cantor Fitzgerald Initiates Coverage of Shattuck Labs (STTK)
2026-05-01 08:17 · Yahoo
Why Shattuck Labs Stock Soared More Than 53% Higher This Week
2026-03-06 22:02 · Yahoo
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights
2026-03-05 11:15 · Yahoo
Shattuck Labs Announces Participation in Upcoming March Investor Conferences
2026-02-25 13:00 · Yahoo
Shattuck Labs Announces Participation in Upcoming Piper Sandler Virtual Novel Targets in Immunology Symposium
2026-02-06 13:30 · Yahoo
Why Shattuck Labs Stock Soared in December
2026-01-06 03:50 · Yahoo
Several Insiders Invested In Shattuck Labs Flagging Positive News
2026-01-05 13:13 · Yahoo
Shattuck Labs, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-12-15 21:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.